| Literature DB >> 26855861 |
Katherine N Gibson-Corley1, Alexander W Boyden1, Mariah R Leidinger1, Allyn M Lambertz1, Georgina Ofori-Amanfo1, Paul W Naumann1, J Adam Goeken1, Nitin J Karandikar1.
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a well-established mouse model for multiple sclerosis and is characterized by infiltration of mononuclear cells and demyelination within the central nervous system along with the clinical symptoms of paralysis. EAE is a multifocal and random disease, which sometimes makes histopathologic analysis of lesions difficult as it may not be possible to predict where lesions will occur, especially when evaluating cross sections of spinal cord. Consequently, lesions may be easily missed due to limited sampling in traditional approaches. To evaluate the entire length of the spinal cord while maintaining anatomic integrity, we have developed a method to section the cord within the decalcified spinal column, which allows for the study of the multifocal nature of this disease and also minimizes handling artifact. HE and Luxol fast blue staining of these spinal cord sections revealed a paucity of lesions in some areas, while others showed marked inflammation and demyelination. The percentage of spinal cord affected by EAE was evaluated at four separate areas of longitudinally sectioned cord and it varied greatly within each animal. Immunohistochemical staining of in situ spinal cords which had undergone decalcification was successful for key immuno-markers used in EAE research including CD3 for T cells, B220 for B cells and F4/80 for murine macrophages. This method will allow investigators to look at the entire spinal cord on a single slide and evaluate the spinal cord with and without classic EAE lesions.Entities:
Keywords: EAE; Histopathology; Mice; Spinal cord
Year: 2016 PMID: 26855861 PMCID: PMC4741089 DOI: 10.7717/peerj.1600
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Clinical scoring rubric for EAE.
| Score | Clinical findings |
|---|---|
| 1 | loss of tail tonicity |
| 2 | mild hind limb weakness |
| 3 | partial hind limb paralysis |
| 4 | complete hind limb paralysis |
| 5 | complete hind limb paralysis with forelimb weakness or moribund |
Figure 1Process of tissue collection and histologic preparation of longitudinally sectioned in situ spinal cord sections.
Primary antibodies and their commercially available sources, catalog numbers, dilutions and specific antigen retrieval conditions utilized in the study.
| Marker | Antibody | Dilution | Source | Conditions |
|---|---|---|---|---|
| CD3 | Cat# RM-9107-5 | 1:200 | Neomarkers | HIER, citrate buffer (pH 6.0) |
| B220 | Cat# MCA1258G | 1:6000 | Serotec | HIER, citrate buffer (pH 6.0) |
| F4/80 | Cat# MCAP497 | 1:6400 | Serotec | HIER, citrate buffer (pH 6.0) |
Figure 2Photomicrographs of decalcified spinal columns from EAE mice.
Longitudinally sectioned spinal cord stained with HE (A) and LFB (D) showing an area which is relatively unaffected (left dotted line) versus one with significant demyelination and inflammatory cell infiltration (right dotted line). The relatively unaffected area corresponds to the HE (B) and Luxol Fast Blue (E) cross sections and the area with lesions corresponds to the HE (C) and Luxol Fast Blue (F) cross sections. Solid arrows indicate areas of inflammation and dotted arrows indicate areas of demyelination. Bars = 200 μm.
Figure 3Clinical EAE score and quantification of the percentage of spinal cord affected by EAE using the method of longitudinal sectioning.
(A) Clinical EAE score (Table 1) of 12 different mice with EAE ranging in age from 7–11 weeks of age. (B) Four separate areas (divided equally cranial to caudal) of longitudinally sectioned spinal cord from the same 12 mice, which were evaluated to determine what percentage of the cord at that area was affected by EAE lesions.
Figure 4Representative images of key immunohistochemical markers run on a longitudinally sectioned, decalcified spinal column from an EAE mouse with a clinical EAE score of 4.
(A) HE, (B) B220 immunohistochemistry for (B) cells, (C) F4/80 immunohistochemistry for macrophages (arrow indicates area highlighted in inset, inset bar = 20 μm), (D) CD3 immunohistochemistry for T cells. Bars = 200 μm.